The bill amends Section 37-2705 of the Idaho Code to classify substances containing mitragynine as Schedule I controlled substances, reflecting growing concerns about the risks and misuse associated with kratom products. This amendment places mitragynine under the same regulatory framework as other controlled substances, enhancing the state's ability to manage its distribution and use. The bill also introduces new legal language that specifically lists mitragynine and its derivatives, including salts and isomers, as controlled substances to ensure more effective regulation.

In addition to the inclusion of mitragynine, the bill expands the list of controlled substances by adding various analogs of phencyclidine, thiofuranyl fentanyl, and compounds that can produce psilocybin or psilocin. It also broadens the classification of depressants and stimulants to include substances like clonazolam, diclazepam, and various cathinones. The bill declares an emergency and sets an effective date of July 1, 2026, underscoring the urgency of addressing substance control in Idaho to enhance public health and safety.

Statutes affected:
Bill Text: 37-2705